5 of 8 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recently posted filings for this company, out of 8. Reading the whole list, and what each filing says: its issues, the agencies contacted and the lobbyists named, is part of the subscription. So is sorting the list by the reported amount. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Lobbying reported per quarter

reported amounts per quarter, latest version of each report

Reported income: what lobbying firms reported receiving from this company's clients, per quarter.

Before 2025, these bars cover only the lobbying relationships that were still active in 2025 or later. Engagements that ended earlier are not included, so those years may be higher than shown.

Reported income

Q1Q2Q3Q4

Recent activity

Register facts only. Everything on this page comes from filings made under the Lobbying Disclosure Act of 1995 and kept by the Secretary of the Senate. We read the filings, we link a client to a listed company where a reviewed rule allows it, and we add nothing else. No score, no ranking and no judgement is attached to lobbying on this site. See the methodology and about this site.

5 of 8 filings

The most recently posted lobbying filings for AZR
Registrant	Filing	Amount	Posted	Source	Registrant	Amount	Filing	All amounts	Posted	Source
RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	2nd Quarter - Termination2nd Quarter 2026	$10,000incomeposted Jul 18, 2026	Jul 18, 2026	LD-2 at lda.gov	RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	$10,000income · Jul 18	2nd Quarter - Termination2nd Quarter 2026	$10,000income	Jul 18, 2026	LD-2 at lda.gov
RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	1st Quarter - Report1st Quarter 2026	$10,000incomeposted Apr 20, 2026	Apr 20, 2026	LD-2 at lda.gov	RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	$10,000income · Apr 20	1st Quarter - Report1st Quarter 2026	$10,000income	Apr 20, 2026	LD-2 at lda.gov
RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	4th Quarter - Report4th Quarter 2025	$10,000incomeposted Jan 20, 2026	Jan 20, 2026	LD-2 at lda.gov	RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	$10,000income · Jan 20	4th Quarter - Report4th Quarter 2025	$10,000income	Jan 20, 2026	LD-2 at lda.gov
RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	3rd Quarter - Report3rd Quarter 2025	$10,000incomeposted Oct 20, 2025	Oct 20, 2025	LD-2 at lda.gov	RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	$10,000income · Oct 20, 2025	3rd Quarter - Report3rd Quarter 2025	$10,000income	Oct 20, 2025	LD-2 at lda.gov
RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	2nd Quarter - Report2nd Quarter 2025	$10,000incomeposted Jul 21, 2025	Jul 21, 2025	LD-2 at lda.gov	RK STRATEGIES, INC.for ADIAL PHARMACEUTICALS, INC.	$10,000income · Jul 21, 2025	2nd Quarter - Report2nd Quarter 2025	$10,000income	Jul 21, 2025	LD-2 at lda.gov

The link between the client names above and AZR is a reviewed rule of ours, not something the filing states: an LD-2 names a client and carries no ticker, no CIK and no LEI.